OTC · BTMDW
biote Corp.
Healthcare · Medical - Care Facilities
$1.61
Up+$0.25 (+18.38%)
Updated Aug 18, 2026, 4:54 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 292.88M
- P/E ratio
- 3.11
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 0
- Avg. volume
- 0
Price performance
BTMDW price history
1M range · 0 trading sessions · Daily adjusted prices
BTMDW does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest BTMDW news
The latest Smart Investors Daily articles mentioning BTMDW.
Stock researchCompany · Overview
BTMDW research
Overview
Company profile and research snapshot.
Company profile
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
